Search research articles
Contact Us
Filters
Showing results (41-50 of 128) with videos related to
Page
of 13
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
May 17, 2019
Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction
Jennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancers
|
August 12, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial
Elahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, et al.
Histopathology
|
August 15, 2023
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype
Jutta Huvila, Emily F Thompson, Jamie Vanden Broek, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol
Aline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2010
Calculator for ovarian carcinoma subtype prediction
Steve E Kalloger, Martin Köbel, Samuel Leung, et al.
JAMA Oncology
|
July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Shuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Oncoimmunology
|
May 24, 2021
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
Elisabeth S Stovgaard, Karama Asleh, Nazia Riaz, et al.
Breast Cancer Research and Treatment
|
January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
Yesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Gynecologic Oncology
|
June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
Amy Jamieson, Melissa K McConechy, Amy Lum, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
October 6, 2021
International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings
Hezhen Ren, Noorah Almadani, Jennifer Pors, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 128) with videos related to
Sort By:
Page
of 13
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
May 17, 2019
Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction
Jennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancers
|
August 12, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial
Elahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, et al.
Histopathology
|
August 15, 2023
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype
Jutta Huvila, Emily F Thompson, Jamie Vanden Broek, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol
Aline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2010
Calculator for ovarian carcinoma subtype prediction
Steve E Kalloger, Martin Köbel, Samuel Leung, et al.
JAMA Oncology
|
July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Shuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Oncoimmunology
|
May 24, 2021
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
Elisabeth S Stovgaard, Karama Asleh, Nazia Riaz, et al.
Breast Cancer Research and Treatment
|
January 26, 2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
Yesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, et al.
Gynecologic Oncology
|
June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
Amy Jamieson, Melissa K McConechy, Amy Lum, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
October 6, 2021
International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings
Hezhen Ren, Noorah Almadani, Jennifer Pors, et al.
Page
of 13